Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease
- 1 August 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 103 (2) , 152-162
- https://doi.org/10.1016/s0002-9343(97)00027-2
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Relation of Glycohemoglobin and Adiposity to Atherosclerosis in YouthArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Oral Antidiabetic AgentsDrugs, 1992
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabeticsDiabetologia, 1977